Kenneth Meisler, DPM
Foot & Ankle Surgery · New York, NYNPI 1215941802
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (32.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Ortho Dermatologics, A Division Of Bausch Health US, LLC accounts for 97.0% of it on its own, with 22 other manufacturers making up the rest. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $235.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$55K
- Abbott$326
- Treace Medical Concepts, Inc.$194
- Sandoz$193
- Sebela Pharmaceuticals Inc.$175
- Stryker$172
- plus $624 from 17 others
What the payments were for
- Consulting fees$15,86328%
- Speaking & faculty fees$18,12532%
- Travel & lodging$15,96228%
- Food & beverage$6,63412%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 180 | $54,902 |
| Abbott | 2 | $326 |
| Treace Medical Concepts, Inc. | 2 | $194 |
| Sandoz | 10 | $193 |
| Sebela Pharmaceuticals Inc. | 11 | $175 |
| Stryker | 1 | $172 |
| Paratek Pharmaceuticals, Inc. | 5 | $88 |
| Zyla Life Sciences, Inc. | 4 | $77 |
| GRT US Holding, Inc. | 3 | $48 |
| Assertio Therapeutics, Inc. | 2 | $48 |
| Alfasigma USA, Inc. | 2 | $46 |
| Dermavant Sciences, Inc. | 2 | $42 |
| Amgen | 2 | $41 |
| Glenmark Therapeutics Inc. | 3 | $35 |
| Melinta Therapeutics, LLC | 2 | $33 |
| Zimmer Biomet | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Dynasplint Systems Inc. | 1 | $27 |
| Bioventus LLC | 1 | $26 |
| Novum Pharma, LLC | 1 | $17 |
| Merck | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JUBLIA$44,822
- SUPERA$326
- PROSTEP MICA$172
- GRAVITY$172
- BIOskin$172
- VARIAX$172
- ORTHOLOC 3DI$172
- SILIQ$151
- Lapiplasty System$116
How this compares
$56,586 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 74 | $70,326 |
| Econazole Nitrate | 66 | $1,970 |
| Tavaborole | 14 | $1,881 |
| Ketoconazole | 59 | $1,831 |
| Mupirocin | 168 | $1,436 |
| Ciclopirox | 46 | $1,350 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 69 | $753 |
| Clotrimazole | 12 | $393 |
| Imiquimod | 12 | $347 |
| Ammonium Lactate | 25 | $342 |
| Silver Sulfadiazine | 20 | $327 |
| CiclopiroxCiclopirox Olamine | 18 | $254 |
| SsdSilver Sulfadiazine | 12 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $54,902 | $70,32674 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.